These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36930514)

  • 21. Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease.
    Shenoy P; Ahmed S; Shanoj KC; Shenoy V; Damodaran D; Menon AR; Alias B; SanjoSaijan ; Devakumar D; Babu ASS
    Clin Rheumatol; 2021 Nov; 40(11):4665-4670. PubMed ID: 34155573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
    Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
    BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and disease burden of autoimmune inflammatory rheumatic diseases after non-pharmaceutical interventions in the COVID-19 era: A nationwide observational study in Korea.
    Shin JH; Pyo JY; Han M; Lee M; Lim SM; Baek JY; Lee JY; Kang JM; Jung I; Ahn JG
    Int J Rheum Dis; 2024 Apr; 27(4):e15144. PubMed ID: 38590055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
    PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey.
    Cherian S; Paul A; Ahmed S; Alias B; Manoj M; Santhosh AK; Varghese DR; Krishnan N; Shenoy P
    Rheumatol Int; 2021 Aug; 41(8):1441-1445. PubMed ID: 34142203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.
    Xiong X; Wong CKH; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Lau KTK; Lee CH; Woo YC; Lui DTW; Wong ICK
    Thyroid; 2022 May; 32(5):505-514. PubMed ID: 35216517
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines.
    Batıbay S; Ulucaköy RK; Günendi Z; Fidan I; Bozdayı G; Göğüş FN
    Inflammopharmacology; 2022 Dec; 30(6):2089-2096. PubMed ID: 36282425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies.
    Gil-Vila A; Ravichandran N; Selva-O'Callaghan A; Sen P; Nune A; Gaur PS; Gonzalez RA; Lilleker JB; Joshi M; Agarwal V; Kardes S; Kim M; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
    Muscle Nerve; 2022 Oct; 66(4):426-437. PubMed ID: 35869701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of familial aggregation of autoimmune rheumatic diseases in Asian Indian patients with systemic lupus erythematosus.
    Ganapati A; Arunachal G; Arya S; Shanmugasundaram D; Jeyaseelan L; Kumar S; Danda S; Danda D
    Rheumatol Int; 2019 Dec; 39(12):2053-2060. PubMed ID: 31263994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
    Ferri C; Ursini F; Gragnani L; Raimondo V; Giuggioli D; Foti R; Caminiti M; Olivo D; Cuomo G; Visentini M; Cacciapaglia F; Pellegrini R; Pigatto E; Urraro T; Naclerio C; Tavoni A; Puccetti L; Varcasia G; Cavazzana I; L'Andolina M; Ruscitti P; Vadacca M; Gigliotti P; La Gualana F; Cozzi F; Spinella A; Visalli E; Dal Bosco Y; Amato G; Masini F; Pagano Mariano G; Brittelli R; Aiello V; Caminiti R; Scorpiniti D; Rechichi G; Ferrari T; Monti M; Elia G; Franceschini F; Meliconi R; Casato M; Iannone F; Giacomelli R; Fallahi P; Santini SA; Zignego AL; Antonelli A
    J Autoimmun; 2021 Dec; 125():102744. PubMed ID: 34781162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases.
    Arumahandi de Silva AN; Frommert LM; Albach FN; Klotsche J; Scholz V; Jeworowski LM; Schwarz T; Ten Hagen A; Zernicke J; Corman VM; Drosten C; Burmester GR; Biesen R
    Ann Rheum Dis; 2022 Jun; 81(6):881-888. PubMed ID: 35288376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines.
    Zhang R; Leung KY; Liu D; Fan Y; Lu L; Chan PC; To KK; Chen H; Yuen KY; Chan KH; Hung IF
    mSphere; 2022 Apr; 7(2):e0091521. PubMed ID: 35285250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort.
    Gasparotto M; Bindoli S; Padoan R; Cozzi G; Depascale R; Zanatta E; Giollo A; Gatto M; Zen M; Schiavon F; Ramonda R; Sfriso P; Doria A; Iaccarino L
    Clin Exp Rheumatol; 2023 Mar; 41(3):642-648. PubMed ID: 35930472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines.
    Wong CKH; Mak LY; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng WY; Cheng FWT; Yuen MF; Wong ICK
    J Hepatol; 2022 Nov; 77(5):1339-1348. PubMed ID: 35817224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey.
    Naveen R; Thakare DR; Kuwana M; Pauling JD; Day J; Joshi M; Parodis I; Sen P; Jagtap K; Nikiphorou E; Saha S; Agarwal V; Chatterjee T; Lilleker JB; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Chinoy H; ; Aggarwal R; Gupta L; Agarwal V; Makol A
    Rheumatol Int; 2023 Jul; 43(7):1265-1275. PubMed ID: 37000295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of COVID-19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta-analysis.
    Al-Haideri M; Mohammad TAM; Darvishzadehdeldari S; Karbasi Z; Alimohammadi M; Faramarzi F; Khorasani S; Rasouli A; Tahmasebi S; Darvishi M; Akhavan-Sigari R
    Int J Rheum Dis; 2023 Jul; 26(7):1227-1234. PubMed ID: 37309305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study.
    Wan EYF; Chui CSL; Mok AHY; Xu W; Yan VKC; Lai FTT; Li X; Wong CKH; Chan EWY; Lui DTW; Tan KCB; Hung IFN; Lam CLK; Leung GM; Wong ICK
    Drug Saf; 2022 Dec; 45(12):1477-1490. PubMed ID: 36184720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine among adolescents with juvenile-onset inflammatory rheumatic diseases.
    Ziv A; Heshin-Bekenstein M; Haviv R; Kivity S; Netzer D; Yaron S; Schur Y; Egert T; Egert Y; Sela Y; Hashkes PJ; Uziel Y
    Rheumatology (Oxford); 2023 Feb; 62(SI2):SI145-SI151. PubMed ID: 35920789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.